Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?
Children · 16.05.2026 · 13 (5) · 683
DOI: 10.3390/children13050683 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 16.05.2026. Verfasst von Elise Casadessus und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology-Oncology, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among the many complications that can occur in individuals with sickle cell disease (SCD), several studies have suspected an increased risk of cancer. While the effect of SCD on solid tumors remains unclear, multiple studies support a higher incidence of leukemia, especially acute myeloid leukemia (AML). This risk seems to appear in childhood and persist throughout life. Based on these features, should SCD be considered a cancer predisposition syndrome? Here, we explore this question by comparing the characteristics of SCD-associated AML and cancer predisposition syndromes. We show that some features are similar. As in cancer predisposition syndrome, increased cancer risk in SCD appears to be restricted to a defined type of malignancy. SCD-associated AML also has molecular specificities reminiscent of therapy-related AML. Many of the mechanisms contributing to SCD-associated leukemogenesis have been reported in cancer predisposition syndromes, including ineffective erythropoiesis, increased cell renewal, chronic inflammation, and oxidative stress. Nevertheless, SCD presents a unique combination of factors, and their magnitude may greatly vary from one individual to another. Strikingly, the relative risk of cancer in SCD is much lower than most cancer predisposition syndromes and closer to those conferred by common variations. This is a major difference, and indeed, the absolute risk of malignancy in individuals with SCD appears to be low. Moreover, SCD has great clinical variability, and the factors influencing AML risk are unclear. In sum, SCD has many specificities compared to cancer predisposition syndromes that should be considered and investigated. Clinicians should be aware of the increased risk of AML in patients’ management and counseling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Hematology-Oncology, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada.
- Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
- CHU Sainte-Justine Azrieli Research Center, Montreal, QC H3T 1C5, Canada.
ORCID-Profile: Thomas Pincez
Zitieren
APA
Casadessus, E., Pastore, Y., & Pincez, T. (2026). Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?. Children, 13(5), 683. https://doi.org/10.3390/children13050683
Vancouver
Casadessus E, Pastore Y, Pincez T. Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?. Children. 2026;13(5):683. doi:10.3390/children13050683
BibTeX
@article{Casadessus2026,
author = {Casadessus, Elise and Pastore, Yves and Pincez, Thomas},
title = {Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?},
journal = {Children},
year = {2026},
volume = {13},
number = {5},
pages = {683},
doi = {10.3390/children13050683}
}
EUVIMED